ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

APRE Aprea Therapeutics Inc

5.36
0.11 (2.10%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Aprea Therapeutics Inc APRE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.11 2.10% 5.36 17:39:08
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.27 5.27 5.45 5.45 5.25
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/2/202416:01EDGAR2Form 8-K - Current report
04/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
02/2/202415:26EDGAR2Form 8-K - Current report
26/1/202406:13EDGAR2Form 8-K - Current report
26/1/202405:03EDGAR2Form S-3 - Registration statement under Securities Act of..
04/1/202415:16EDGAR2Form 8-K - Current report
09/11/202315:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202315:15EDGAR2Form 8-K - Current report
09/11/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/10/202316:29EDGAR2Form 8-K - Current report
13/10/202306:31EDGAR2Form 8-K - Current report
11/9/202307:30EDGAR2Form 8-K - Current report
24/8/202320:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202320:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202320:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202307:00EDGAR2Form 8-K - Current report
10/8/202306:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:36EDGAR2Form 8-K - Current report
11/7/202306:30EDGAR2Form DEF 14A - Other definitive proxy statements
05/7/202315:01EDGAR2Form 8-K - Current report
14/6/202307:00GLOBEAprea Therapeutics to Present at Maxim Virtual Healthcare..
30/5/202307:30GLOBEAprea Therapeutics to Present at BIO International..
15/5/202315:05GLOBEAprea Therapeutics Reports First Quarter 2023 Financial..
08/5/202307:00GLOBEAprea Therapeutics Appoints Gabriela Gruia, M.D. to Board of..

Su Consulta Reciente

Delayed Upgrade Clock